Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8321517rdf:typepubmed:Citationlld:pubmed
pubmed-article:8321517lifeskim:mentionsumls-concept:C0034493lld:lifeskim
pubmed-article:8321517lifeskim:mentionsumls-concept:C0037473lld:lifeskim
pubmed-article:8321517lifeskim:mentionsumls-concept:C0117881lld:lifeskim
pubmed-article:8321517lifeskim:mentionsumls-concept:C1517572lld:lifeskim
pubmed-article:8321517lifeskim:mentionsumls-concept:C1656863lld:lifeskim
pubmed-article:8321517pubmed:issue2lld:pubmed
pubmed-article:8321517pubmed:dateCreated1993-8-5lld:pubmed
pubmed-article:8321517pubmed:abstractTextWe studied the intraocular concentration of flomoxef sodium in nonvitrectomized and vitrectomized eyes of albino rabbits after intravenous administration of 100 mg/kg flomoxef sodium. The concentration of flomoxef sodium in the vitreous body was undetectable (< 0.1 micrograms/ml) in nonvitrectomized eyes. Retinal toxicity of flomoxef sodium was investigated with ophthalmoscopy, electroretinography (ERG) and light microscopy after intravitreal injection of 200, 500, 1,000 and 2,000 micrograms flomoxef sodium in albino and pigmented rabbits. No ERG changes were induced with 200 micrograms. Other higher doses caused transient ERG changes. After the 200-micrograms injection, the intravitreal concentration decreased exponentially, the half-life being 4.4 h. The antibacterial activity, broad coverage and low intravitreal toxicity of flomoxef sodium suggest that this compound may be used to treat bacterial endophthalmitis.lld:pubmed
pubmed-article:8321517pubmed:languageenglld:pubmed
pubmed-article:8321517pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8321517pubmed:citationSubsetIMlld:pubmed
pubmed-article:8321517pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8321517pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8321517pubmed:statusMEDLINElld:pubmed
pubmed-article:8321517pubmed:issn0030-3747lld:pubmed
pubmed-article:8321517pubmed:authorpubmed-author:TanahashiTTlld:pubmed
pubmed-article:8321517pubmed:authorpubmed-author:KomatsuMMlld:pubmed
pubmed-article:8321517pubmed:authorpubmed-author:MochizukiKKlld:pubmed
pubmed-article:8321517pubmed:authorpubmed-author:YamashitaYYlld:pubmed
pubmed-article:8321517pubmed:authorpubmed-author:TorisakiMMlld:pubmed
pubmed-article:8321517pubmed:issnTypePrintlld:pubmed
pubmed-article:8321517pubmed:volume25lld:pubmed
pubmed-article:8321517pubmed:ownerNLMlld:pubmed
pubmed-article:8321517pubmed:authorsCompleteYlld:pubmed
pubmed-article:8321517pubmed:pagination128-36lld:pubmed
pubmed-article:8321517pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8321517pubmed:meshHeadingpubmed-meshheading:8321517-...lld:pubmed
pubmed-article:8321517pubmed:meshHeadingpubmed-meshheading:8321517-...lld:pubmed
pubmed-article:8321517pubmed:meshHeadingpubmed-meshheading:8321517-...lld:pubmed
pubmed-article:8321517pubmed:meshHeadingpubmed-meshheading:8321517-...lld:pubmed
pubmed-article:8321517pubmed:meshHeadingpubmed-meshheading:8321517-...lld:pubmed
pubmed-article:8321517pubmed:meshHeadingpubmed-meshheading:8321517-...lld:pubmed
pubmed-article:8321517pubmed:meshHeadingpubmed-meshheading:8321517-...lld:pubmed
pubmed-article:8321517pubmed:meshHeadingpubmed-meshheading:8321517-...lld:pubmed
pubmed-article:8321517pubmed:meshHeadingpubmed-meshheading:8321517-...lld:pubmed
pubmed-article:8321517pubmed:meshHeadingpubmed-meshheading:8321517-...lld:pubmed
pubmed-article:8321517pubmed:year1993lld:pubmed
pubmed-article:8321517pubmed:articleTitleIntravitreal flomoxef sodium in rabbits.lld:pubmed
pubmed-article:8321517pubmed:affiliationDepartment of Ophthalmology, School of Medicine, Kanazawa University, Japan.lld:pubmed
pubmed-article:8321517pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8321517pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed